Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults
National Institute of Allergy and Infectious Diseases (NIAID)
Glenda E Gray; Linda-Gail Bekker; Fatima Laher; Mookho Malahleha; Mary Allen; Zoe Moodie; Nicole Grunenberg; Yunda Huang; Doug Grove; Brittany Prigmore; Jia J Kee; David Benkeser; John Hural; Craig Innes; Erica Lazarus; Graeme Meintjes; Nivashnee Naicker; Dishiki Kalonji; Maphoshane Nchabeleng; Modulakgotla Sebe; Nishanta Singh; Philip Kotze; Sheetal Kassim; Thozama Dubula; Vimla Naicker; William Brumskine; Cleon N Ncayiya; Amy M Ward; Nigel Garrett; Girisha Kistnasami; Zakir Gaffoor; Pearl Selepe; Philisiwe B Makhoba; Matsontso P Mathebula; Pamela Mda; Tania Adonis; Katlego S Mapetla; Bontle Modibedi; Tricia Philip; Gladys Kobane; Carter Bentley; Shelly Ramirez; Simbarashe Takuva; Megan Jones; Mpho Sikhosana; Millicent Atujuna; Michele Andrasik; Nima S Hejazi; Adrian Puren; Lubbe Wiesner; Sanjay Phogat; Carlos Diaz Granados; Marguerite Koutsoukos; Olivier Van Der Meeren; Susan W Barnett; Niranjan Kanesa-Thasan; James G Kublin; M Juliana McElrath; Peter B Gilbert; Holly Janes; Lawrence Corey; HVTN 702 Study Team